Chronic inflammation of the joints – the transition from pediatric rheumatologist to adult rheumatologist. Recommendations of the Panel of Experts on National Consultant in the field of rheumatology (recommendations in the context of the conditions relating to compliance)
More details
Hide details
Submission date: 2013-04-10
Acceptance date: 2013-06-11
Online publication date: 2013-09-11
Publication date: 2013-10-30
Reumatologia 2013;51(4):259–264
Juvenile idiopathic arthritis (JIA) has many clinical manifestations. In several tens of percent of patients with JIA, significant disease activity remains in adulthood, in addition to short stature, physical disability, osteoporosis, dysfunction of internal organs and eyes. Sometimes amyloidosis is a complication of the disease. The individual forms of JIA frequently take the clinical presentation of their equivalents – chronic inflammation of joints, classified in adults. Some undifferentiated forms of JIA still remain undifferentiated. A separate clinical picture during the total disease period in children and adults usually has persistent form of oligoarthritis of JIA with the presence of antinuclear antibodies with or without uveitis. In adults the amount of medications approved for the treatment of chronic arthritis is higher than in children. Strict separation in the records of drug programs for JIA and for arthritis in adults makes it difficult to continue treatment after reaching adulthood.
Rutkowska-Sak L. Młodzieńcze idiopatyczne zapalenie stawów – meandry klasyfikacji. Reumatologia 2011; 49: 351-353.
Petty RE, Southwood TR, Manners P, et al.; International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-392.
Rutkowska-Sak L, Gietka P, Wierzbowska M i wsp. Reumatologia wieku rozwojowego. Reumatologia 2012; 50: 142-161.
De Benedetti F, Schneider R Systemic juvenile idiopathic arthritis. In: Textbook of Pediatric Rheumatology. 6th ed. Cassidy JT, Petty RE, Laxer RM, Lindsley CB (eds.). Elsevier, Philadelphia 2011; 236-248.
Beukelman T, Patkar NM, Saag KG, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 2011; 63: 465-482.
Quartier P, Taupin P, Bourdeaut F, et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 2003; 48: 1093-1101.
Kimura Y, Pinho P, Walco G, et al. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis. J Rheumatol 2005; 32: 935-942.
Yokota S, Imagawa T, Mori M, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 2008; 371: 998-1006.
Ruperto N, Lovell DJ, Cuttica R, et al.; Paediatric Rheumatology INternational Trials Organization (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG). Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Ann Rheum Dis 2010; 69: 718-722.
Tuková J, Chládek J, Nemcová D, et al. Methotrexate bioavailability after oral and subcutaneous dministration in children with juvenile idiopathic arthritis. Clin Exp Rheumatol 2009; 27: 1047-1053.
Camuglia JE, Whitford CL, Hall AJ. Juvenile idiopathic arthritis associated uveitis in adults: a case series. Ocul Immunol Inflamm 2009; 17: 330-334.
Skarin A, Elborgh R, Edlund E, Bengtsson-Stigmar E. Long-term follow-up of patients with uveitis associated with juvenile idiopathic arthritis: a cohort study. Ocul Immunol Inflamm 2009; 17: 104-108.
Minden K. Adult outcomes of patients with juvenile idiopathic arthritis. Horm Res 2009; 72 Suppl 1: 20-25.
Hämäläinen H, Arkela-Kautiainen M, Kautiainen H, et al. Bone mineral content in young adults with active or inactive juvenile idiopathic arthritis and in controls. Scand J Rheumatol 2010; 39: 219-222.
Nordal E, Zak M, Aalto K, et al. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 2011; 63: 2809-2818.
Parvez N, Carpenter JL. Cardiac tamponade in Still disease: a review of the literature. South Med J 2009; 102: 832-837.
Muszyński P, Składzień J, Reroń E, et al. Transient evoked otoacustic emission in children with juvenile idiopathic arthritis. Otolaryngol Pol 2007; 61: 972-978.
Ravelli A, Felici E, Magni-Manzoni S, et al. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheum 2005; 52: 826-832.
Arvidsson LZ, Flato/ B, Larheim TA. Radiographic TMJ abnormalities in patients with juvenile idiopathic arthritis followed for 27 years. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 114-123.
Arvidsson LZ, Smith HJ, Flato/ B, Larheim TA. Temporomandibular joint findings in adults with long-standing juvenile idiopathic arthritis: CT and MR imaging assessment. Radiology 2010; 256: 191-200.
Flato/ B, Lien G, Smerdel-Ramoya A, Vinje O. Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis. J Rheumatol 2009; 36: 642-650.
Burgos-Vargas R, Vázquez-Mellado J. The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis. Arthritis Rheum 1995; 38: 835-844.
Sheerin KA, Giannini EH, Brewer EJ Jr, Barron KS. HLA-B27-associated arthropathy in childhood: long-term clinical and diagnostic outcome. Arthritis Rheum 1988; 31: 1165-1170.
Burgos-Vargas R, Clark P. Axial involvement in the seronegative enthesopathy and arthropathy syndrome and its progression to ankylosing spondylitis. J Rheumatol 1989;16: 192-197.
O'Shea FD, Boyle E, Riarh R, et al. Comparison of clinical and radiographic severity of juvenile-onset versus adult-onset ankylosing spondylitis. Ann Rheum Dis 2009; 68: 1407-1412.
Gensler LS, Ward MM, Reveille JD, et al. Clinical, radiographic and functional differences between juvenile-onset and adult-onset ankylosing spondylitis: results from the PSOAS Cohort. Ann Rheum Dis 2008; 67: 233-237.
Malviya A, Johnson-Lynn S, Avery P, et al. Juvenile idiopathic arthritis in adulthood and orthopaedic intervention. Clin Rheumatol 2009; 28: 1411-1417.
Ringold S, Chon Y, Singer NG. Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: a secondary analysis of clinical trial data from children with polyarticular-course juvenile idiopathic arthritis. Arthritis Rheum 2009; 60: 3776-3783.
Martini A. It is time to rethink juvenile idiopathic arthritis classification and nomenclature. Ann Rheum Dis 2012; 71: 1437-1439.
Hashkes PJ, Wright BM, Lauer MS, et al. Mortality outcomes in pediatric rheumatology in the US. Arthritis Rheum 2010; 62: 599-608.
Zimmermann-Górska I. Kontynuacja monitorowania przebiegu chorób reumatycznych u osób po 18. roku życia – spojrzenie internisty. Reumatologia 2013; 51, 1: 46-50.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.